Capstone Financial Advisors, Inc. Bristol Myers Squibb CO Transaction History
Capstone Financial Advisors, Inc.
- $1.49 Billion
- Q1 2024
A detailed history of Capstone Financial Advisors, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Capstone Financial Advisors, Inc. holds 22,138 shares of BMY stock, worth $943,964. This represents 0.08% of its overall portfolio holdings.
Number of Shares
22,138
Previous 14,208
55.81%
Holding current value
$943,964
Previous $729,000
64.61%
% of portfolio
0.08%
Previous 0.05%
Shares
15 transactions
Others Institutions Holding BMY
# of Institutions
2,499Shares Held
1.49BCall Options Held
25.9MPut Options Held
20M-
Vanguard Group Inc Valley Forge, PA186MShares$7.93 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY163MShares$6.93 Billion0.21% of portfolio
-
State Street Corp Boston, MA91.6MShares$3.9 Billion0.23% of portfolio
-
Jpmorgan Chase & CO New York, NY88.8MShares$3.79 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$2.99 Billion0.79% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $90.7B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...